Enovis Corp. (ENOV)
23.97
-0.29
(-1.20%)
USD |
NYSE |
Jan 16, 16:00
23.63
-0.34
(-1.42%)
Pre-Market: 20:00
Enovis EPS Diluted (Quarterly): -9.990 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Repligen Corp. | 0.2638 |
| Twist Bioscience Corp. | -0.4491 |
| Perspective Therapeutics, Inc. | -0.3495 |
| InfuSystem Holdings, Inc. | 0.1078 |
| Xtant Medical Holdings, Inc. | 0.0087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -570.87M |
| Revenue (Quarterly) | 548.91M |
| Total Expenses (Quarterly) | 1.120B |
| Enterprise Value | 2.781B |
| Gross Profit Margin (Quarterly) | 52.24% |
| Profit Margin (Quarterly) | -104.0% |
| Earnings Yield | -101.0% |
| Normalized Earnings Yield | -34.72 |